Skip to content

Evaluation of the effectiveness of topical formulation of Falcaria vulgaris extract in patients with vitiligo

Evaluation of the effectiveness of topical formulation of Falcaria vulgaris extract in patients with vitiligo

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230930059569N1
Enrollment
36
Registered
2024-03-13
Start date
2024-10-05
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo.

Interventions

Intervention 1: Intervention group: topical cream of Falcaria vulgaris extract, 3% w/w, once daily, for 3 months, apply topical to affected areas. Intervention 2: Control group: betamethasone (as Vale

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with mild to moderate vitiligo Patients who have at least two symmetric skin lesions Not suffering from skin diseases, such as allergies, etc. Not suffering from light-sensitive diseases such as lupus and porphyria, Not using photosensitizing drugs such as retinoids Patients who have not received systemic treatment for vitiligo in the past one month and during this period Patients with lesions that are homogeneous in terms of size, location, and duration of the lesion, and stable so that the lesion did not spread for at least the last 6 months.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patients with severe vitiligo History of contact dermatitis Having other skin diseases that affect the study Patient dissatisfaction Case of drug allergy Face and axillary and inguinal region involvement Mentally retarded patient

Design outcomes

Primary

MeasureTime frame
The size of lesions. Timepoint: At the beginning of the study (before the start of the intervention) and 1, 2 and 3 months after the use of topical treatments. Method of measurement: Based on the Vitiligo Area Scoring Index - using the hand unit and the amount of depigmentation of the lesion.;Repigmentation percent. Timepoint: 1, 2 and 3 months after the use of topical treatments. Method of measurement: Observationally by comparing with the photograph of the lesion before starting the intervention.

Secondary

MeasureTime frame
Noticeability of lesions. Timepoint: At the end of the study (3 months after the beginning of the intervention). Method of measurement: Vitiligo Noticeability Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSanam Javadzadeh

Tabriz University of Medical Sciences

sanam.javadzadeh@yahoo.com+98 21 8803 7355

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026